Josh Mandel-Brehm - 11 Dec 2025 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
Chief Executive Officer, Director
Signature
/s/ Kelly Gold, as Attorney-in-Fact
Issuer symbol
CAMP
Transactions as of
11 Dec 2025
Net transactions value
$0
Form type
4
Filing time
22 Dec 2025, 17:41:14 UTC
Previous filing
11 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mandel-Brehm Josh Chief Executive Officer, Director C/O CAMP4 THERAPEUTICS CORPORATION, ONE KENDALL SQ., BLDG 1400 WEST, 3RD FL., CAMBRIDGE /s/ Kelly Gold, as Attorney-in-Fact 22 Dec 2025 0001927058

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAMP Stock Option (Right to Buy) Award $0 +425,000 $0.000000 425,000 11 Dec 2025 Common Stock 425,000 $6.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option has a vesting start date of December 1, 2025 and vests as to one third (33.33%) of the shares subject to the option on the first anniversary of the vesting start date and as to the remaining shares in equal monthly installments over 24 months thereafter, subject to continued service.